UAB and Children’s of Alabama launch new urine collection device for critically ill premature infants and children

Nugent honored as one of 2022’s “Top Birmingham Women”

University of Alabama at Birmingham (UAB) Associate Vice President Kathy Nugent, Ph.D., was announced as one of the Top Birmingham Women of 2022 by the Birmingham Business Journal.

UAB start-up aims to develop inhaled therapies for lung conditions

C. Vivek Lal, M.D., FAAP, knows the challenge of launching a successful start-up.

Less than two years ago, Lal founded ResBiotic, a UAB start-up company that creates science-backed, clinically tested over-the-counter probiotics to support gut, lung and immune health by targeting the gut microbiome.

UAB’s newest start-up nurtures neonates

Earlier in his career, David Askenazi, M.D., MPH, heard a colleague speak about how important medical innovation is and how academics should devote time and effort to inventing devices and products to aid patients’ health, rather than only focusing on observing and reporting.

“He said that in order to change the course of those we encounter in our daily rounds, we must bring innovations to the bedside,” Askenazi said. “After all, we have a front row seat in understanding where the gaps in optimal care exist.”

Seven UAB start-ups receive grants from Alabama Innovation Corporation

The Alabama Innovation Corporation named the first round of small business recipients of the Innovate Alabama Supplemental Grant Program, seven of which are UAB start-ups.

Kwan uses knowledge gleaned as an Innovate fellow to prepare the next generation

SBIR/STTR recipients eligible to apply for up to $250k in state funding

The Alabama Innovation Corporation, also known as Innovate Alabama, recently opened applications for the Innovate Alabama Supplemental Grant Program. 

State-based recipients of Phase I and Phase II Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants are eligible to apply for up to $250,000 in supplemental funding. 

UAB start-up acquired by Eurofins Discovery Panlabs

A UAB start-up company specializing in custom human cell engineering and drug discovery and commercialization has been acquired by an international drug discovery company.

For he’s a jolly good Fellow

When Thaddaeus Kwan was finishing his undergraduate degree at small Houghton College in New York, he knew he was interested in molecular biology and the study of various diseases, but wasn’t ready to commit to a specific field of study.

That desire for flexibility brought him to UAB, where he was recruited by the Pathobiology and Molecular Medicine division in the Graduate Biomedical Sciences program. Whereas some graduate programs would have required him to quickly settle on a research path, UAB’s program allowed him to explore the diverse avenues available.

Early, encouraging data for glioblastoma treatment reported at ASCO

UAB start-up company revolutionizing production of nanofibers

Open the doors at TruSpin, and one’s eyes are immediately drawn to a machine spinning out a dense, wispy web onto an enormous spool suspended from above.

While this might look like a mad scientist’s method for making cotton candy, it’s actually the future of nanofiber manufacturing, and the nanofibers created have the potential for seismic impact in the scientific world.

UAB start-up awarded $1 million grant to fight Shigella infections

UAB start-up SunFire Biotechnologies LLC was awarded a grant by the U.S. Department of Defense to continue advancing an assay to support the development of Shigella vaccines.